BRE-13: Mediterranean Diet (BRE-13)
BRE-13: Mediterranean Diet-A Presurgical Window of Opportunity Trial Among Women With Breast Cancer
Explore the effect of MedDiet vs. Usual Diet on circulating and breast tumor fatty acid profiles. The investigators aim to examine impact on tumor biology in newly diagnosed participants.
調査の概要
状態
詳細な説明
Conduct a 3-week presurgical window trial among 30 women with stage I-III luminal breast cancer. Participants will be randomized 1:1 to a controlled MedDiet or an enhanced usual-care control. This study will generate critical translational data on how dietary fat composition influences tumor metabolism and immune response, informing future diet-based cancer interventions.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Lisa Marie Tussing-Humphreys, Ph.D.
- 電話番号:312 355 5521
- メール:tussing@uic.edu
研究連絡先のバックアップ
- 名前:Meredith Russell
- 電話番号:312 355 5112
- メール:mrussel3@uic.edu
研究場所
-
-
Illinois
-
Chicago、Illinois、アメリカ、60612
- 募集
- University of Illinois at Chicago Campus
-
コンタクト:
- Meredith Russell, BS
- 電話番号:312 355 5112
- メール:mrussel3@uic.edu
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Age ≥ 18 years;
- Newly diagnosed stage I-III luminal breast cancer
- Planned surgical resection at UI Health
- Ability to speak, read, write, and understand English
- A Mediterranean Eating Pattern for Americans (MEPA-III) score <13 indicating that they do not currently follow a MedDiet;
- ECOG performance status of 0 or 1.
Exclusion Criteria:
- Currently following a MedDiet, vegan diet, or dietary restrictions (e.g., religious, food intolerance/allergy) that preclude adoption of a MedDiet;
- Lack of access to a space to safely store and reheat foods items;
- Living in facility that provides meals;
- Chronic CKD stage 3+ or currently receiving dialysis treatment;
- History of GI surgery involving removal of part of the stomach or intestines;
- Type 1 or Type 2 diabetes;
- Autoimmune or Inflammatory disease or immunocompromised; and
- Cachexia.
We will not exclude other neoadjuvant treatments. Adults unable to consent Individuals who are not yet adults (infants, children, teenagers) Pregnant or breastfeeding women Prisoners
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Med Diet
Mediterranean Diet (MedDiet) is a dietary pattern characterized by a low intake of saturated fats and a high intake of unsaturated fats, with olive oil as the primary culinary fat (7, 8). |
Fatty acid profile (chain length and degree of saturation) in circulation of blood, tumor tissue, and tumor interstitial fluid. Fatty acid profile (chain length and degree of saturation) in breast tumor tissue. Lipid availability in blood, tumor tissue, and tumor interstitial fluid. Tumor tissue will explore the effect of MedDiet vs. Usual Diet on tumor proliferation (Ki67) and expression of NK and CD8 T cells and chylomicrons (Apo48 staining). |
|
介入なし:Usual Diet
Dietary fat and cancer has been conducted in preclinical models of diet-induced obesity, where high-fat diets promote tumor growth |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Aim 1a
時間枠:3 weeks
|
Fatty acid profile (chain length and degree of saturation) in blood. |
3 weeks
|
|
Aim 1b
時間枠:3 weeks
|
Lipid availability in blood, tumor tissue, and interstitial fluid. |
3 weeks
|
|
Aim 1c
時間枠:3 weeks
|
Fatty acid profile (chain length and degree of saturation) in breast tumor tissue, |
3 weeks
|
|
Aim 2a
時間枠:3 weeks
|
peripheral blood monocyte cells from the electronic health record. |
3 weeks
|
|
Aim 2b
時間枠:3 weeks
|
Tumor tissue will explore the effects on tumor proliferation (Ki67) cells. |
3 weeks
|
|
Aim 2c
時間枠:3 weeks
|
Tumor tissue will explore the effects on expression of NK cells. |
3 weeks
|
|
Aim 2d
時間枠:3 weeks
|
Tumor tissue will explore the effects on CD8 T cells(immunohistochemistry) cells. |
3 weeks
|
|
Aim 2e
時間枠:3 weeks
|
Tumor tissue will explore the effects on chylomicrons (Apo48 staining) cells. |
3 weeks
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Exploratory aim a
時間枠:3weeks
|
Stool will be used to analyze gut microbiome changes using shotgun bioinformatics and downstream bioinformatics to study compositional and metabolic changes among the two study arms. |
3weeks
|
|
Exploratory aim b
時間枠:3weeks
|
Stool will be used to analyze downstream bioinformatics to study compositional and metabolic changes among the two study arms. |
3weeks
|
|
Exploratory aim c
時間枠:3weeks
|
Stool will be used to analyze metabolic changes among the two study arms. |
3weeks
|
協力者と研究者
捜査官
- 主任研究者:Lisa Marie Tussing-Humphreys, Ph.D、University of Illinois Chicago Campus
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。